15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 15 firms covering Nutanix Inc, 9 rate it Buy or better, 6 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $50.00 to $90.00, a moderate spread. The average target of $71.43 sits 6% above the current $67.51. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.63 next quarter toward $2.66 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS15 ratings
Moderate Buy
Strong Buy00%
Buy960%
Hold640%
Sell00%
Strong Sell00%
Based on 15 analysts giving stock ratings to Nutanix Inc.
As of Sep, 9 of 15 firms rate NTNX a Buy (6 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
NTNX EPS & revenue forecast
EPS · NEXT QUARTER
$0.63
Range $0.55 – $0.73 · 15 analysts · +13% YoY
Next period, 15 analysts expect Nutanix Inc to earn $0.63 a share (range $0.55 – $0.73), versus $0.56 a year earlier. Full-year consensus is $2.31, growing to $2.66 the year after.
REVENUE · NEXT QUARTER
$820.7M
Range $810.0M – $854.3M · 15 analysts · +14% YoY
Revenue is expected to reach $820.7M (range $810.0M – $854.3M), +13.5% year-over-year. Full-year consensus is $3.2B, rising to $3.7B next year.
Top analysts covering Nutanix Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NTNX.
#1
Samik Chatterjee
JP Morgan · Rank #59
Hold
$50.00-25.9% to target
Overall win rate
49%
+ Follow
#2
Simon Leopold
Raymond James · Rank #320
Hold
No targeton NTNX
Overall win rate
32%
+ Follow
#3
Nehal Chokshi
Northland Capital Markets · Rank #349
Hold
$47.00-30.4% to target
Overall win rate
30%
+ Follow
#4
Matthew Hedberg
RBC Capital
Buy
$90.00+33.3% to target
Coverage
—
+ Follow
#5
Tim Long
Barclays
Hold
$75.00+11.1% to target
Coverage
—
+ Follow
NTNX stock forecast FAQ
What is NTNX's average 12-month price target?+
The 14 analysts with a live target average $71.43 for Nutanix Inc over the next 12 months, ranging from a $90.00 high to a $50.00 low.
Is NTNX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 15 analyst ratings, 9 are Buy or Strong Buy, 6 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for NTNX?+
The Street-high target is $90.00 (RBC Capital), and the Street-low is $50.00 (JP Morgan). The average of all 14 active targets is $71.43.
How many Wall Street analysts cover NTNX?+
15 analysts have an active rating on Nutanix Inc, and 14 firms carry a live 12-month price target.
Who is the most accurate analyst covering NTNX?+
Among analysts who currently cover NTNX, Samik Chatterjee of JP Morgan has the strongest overall Quantellect track record (Rank #59). Their current call is Hold with a $50.00 target.
What is Nutanix Inc's projected EPS for next quarter?+
The consensus estimate is $0.63 per share (range $0.55 – $0.73) across 15 analysts. Full-year EPS is projected at $2.31, rising to $2.66 the following year.
How much revenue is Nutanix Inc expected to report next quarter?+
Consensus revenue is $820.7M (range $810.0M – $854.3M). Full-year revenue is projected at $3.2B, growing to $3.7B next year.
Have analysts been upgrading or downgrading NTNX lately?+
As of Sep, 9 of 15 firms rate NTNX a Buy (6 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NTNX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
